End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.84 CNY | -0.25% | +6.67% | +8.20% |
04-23 | Cisen Pharmaceutical Names Chief Financial Officer | MT |
04-22 | Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 4.07B 562M 44.75B | Sales 2023 | 4.46B 617M 49.11B | Capitalization | 6.6B 913M 72.65B |
---|---|---|---|---|---|
Net income 2022 | 350M 48.4M 3.85B | Net income 2023 | 521M 72.04M 5.73B | EV / Sales 2022 | 0.75 x |
Net cash position 2022 | 2.63B 363M 28.89B | Net cash position 2023 | 2.6B 360M 28.67B | EV / Sales 2023 | 0.9 x |
P/E ratio 2022 |
16.4
x | P/E ratio 2023 |
12.7
x | Employees | 3,402 |
Yield 2022 |
2.66% | Yield 2023 |
2.98% | Free-Float | 37.78% |
1 day | -0.25% | ||
1 week | +6.67% | ||
Current month | +10.31% | ||
1 month | +11.24% | ||
3 months | +3.73% | ||
6 months | +13.30% | ||
Current year | +8.20% |
Managers | Title | Age | Since |
---|---|---|---|
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 05/11/98 |
En Long Zhao
CHM | Chairman | 45 | 30/06/04 |
Xin Bang Xu
DFI | Director of Finance/CFO | 46 | 31/07/00 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Zhang
BRD | Director/Board Member | 59 | 27/11/17 |
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 05/11/98 |
Xin Sheng Sun
BRD | Director/Board Member | 71 | 27/11/17 |
Date | Price | Change | Volume |
---|---|---|---|
28/04/24 | 15.84 | -0.25% | 4 540 933 |
26/04/24 | 15.88 | -1.24% | 5,265,387 |
25/04/24 | 16.08 | +0.82% | 6,333,850 |
24/04/24 | 15.95 | +2.97% | 6,741,115 |
23/04/24 | 15.49 | +1.64% | 10,423,500 |
End-of-day quote Shanghai S.E., April 28, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+8.20% | 992M | |
+20.81% | 43.34B | |
+20.44% | 21.96B | |
+13.30% | 14.09B | |
+12.97% | 13.64B | |
+39.74% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- 603367 Stock